Peficitinib, a investigational compound targeting this specific kinase, presents a possible advance in the treatment of RA . Early patient studies suggest that it can effectively lessen discomfort https://peficitinib507125.blogdigy.com/peficitinib-a-promising-treatment-for-rheumatoid-inflammation-69245347